Here is a link to the latest SEC filing by Joseph P. Daly showing that he bought over 5%
of MFIC in Feb 2007.

http://www.sec.gov/Archives/edgar/data/723889/000133259607000003/sched13d.txt

"Mr. Daly is the chief executive of Essig Research Incorporated. Essig Research offers
global engineering services."

"As part of his ongoing review of his investment in the Shares, Mr. Daly may explore from
time to time a variety of alternatives, including the acquisition of additional securities
of the Issuer"

The CEO, Irv Gruverman, once told Andre in a conference call that he gets offers all the
time to take the company private. Irv then went on to say that most offers were for less
that the $5 or more that he thought the company was worth and that is where things would
usually (but not always) would end.

Joe Daly, the head of a private engineering company has recently bought over 5% of the
company per an SEC filing. He may have made an offer an offer for the company and been
turned down. There also has been speculation that he might merge his firm with that of
MFIC and the combined company would easily be big enough to list on the NASDAQ and also be
included in the Russell small cap, and other Major index's

Do anyone know if the CEO and largest shareholder is likely to retire and/or sell the
company? The CEO is 73 and the COO is 69 per yahoo.

With products in the door of thousands of drug companies and research institions I would
think a number of companies would want MFIC just for the contacts.

I also heard that the owner of a private engineering company is buying up shares in MFIC.

Within the next seven days, MFIC will release its 2006 10-K. It will be interesting to
see if the "consensus analyst" forecast of 1 cent for the quarter and 4 cents for the year
is correct....or the 10 cents for the quarter and 12 to 13 cents for the year as the
company's investors are predicting becaomes correct. I have never seen such a huge
discrepancy between what the analysts are saying and what a reasonable analysis, given the
company's pre-release of Q4 revenues, seems to indicate.

scambuster and two of us,

I can well understand your skepticism in regards to my 13 or so cents 2006 earnings
forecast for MFIC. After all, as you've correctly stated, and as cnbc.com will reveal,
the First Call analysts' consensus is for 1 cent for Q4 and 4 cents for the entire year.

However, in the case of MFIC, I think the consensus analyst's forecast is dead wrong, and
dead wrong by a longshot. Please examine, if you care to, my analysis in a "Possible 2006
10-K Net Income" thread in Yahoo! Finance. Alternatively, please go to otcspeculator.com,
click on "MFIC" in the leftmost column, and read my comments to Thomas Kelly's second
entry with regard to MFIC.

Qs 1 through 3, all profitable, have already been reported in great detail. As to Q4, the
company has already reported unaudited preliminary revenues. Armed with that preliminary
revenue information, knowing the company's ballpark profit margin, and furthermore having
the first three quarters as a guide in estimating Q4 R&D, general and administrative, and
selling operating expenses, I believe a pretty good forecast can be developed. And after
doing so, there's no possible conclusion other than 4 cents being utterly unrealistic,
woefully anemic, and, again, dead wrong.

And, of course, that discrepancy between what "the market" believes and what may very well
be reported is where opportunity lies.

I just checked to see what the analysts are predicting for Q4 earnings for MFIC and it's
only 1 cent. So if they got 2 to 3 cents for the first three quarters, and they're going
to get 1 cent for the fourth, how do you get anywhere above 10 cents? Or anywhere above 5
cents? Shame on you for trying to scam people!

I owned it when it was higher, then it came down and I bought more, and now, after the $5
million quarter, it's drifted up a ways. There have been some decent volume days just
recently, but it's still a very much undiscovered company. Part of the problem is that
the company is zero hype. They presented at zero investor conferences last year...and
rarely issue news releases...while other HUGE money losing nano companies attend every
conceivable nano conference...and make mountains out of the most insignificant molehills
in news releases... and have market caps in the hundreds of millions. :-) I guess this
company is trying hard to sell its products and not, as yet, its company's shares.
Although they apparently were invited to give an interview on mn1.com which was a pleasant
surprise (hence the mini-run of late).

not much volume in it right now???

ok great I'm going to short it...ok I was kidding seems like it has a had a pretty good
run.....did you own it before the run or just now in it

Last edited on: 03-06-2007 01:25 pm

As far as this company being a "high spec" investment opportunity, not only do they make
money, but their trademarked Microfluidizer is cited thousands of times in end users'
patents (do a search for issued patents or patent applications at uspto.gov). Those
thousands of already placed pieces of lab equipment or production systems means
substantial revenues earned through replacement parts that are, at present, 35% or so of
annual revenues. Each incremental sale, therefore, gives the company immediate, high
profit margin income as well as a cash flow stream over time, similar to printer companies
that make megabucks in selling replacement cartridges.